Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 09:46:45 UTC |
---|
Update Date | 2021-09-26 23:04:29 UTC |
---|
HMDB ID | HMDB0252099 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Etilamfetamine |
---|
Description | Etilamfetamine, also known as ethylamphetamine, belongs to the class of organic compounds known as amphetamines and derivatives. These are organic compounds containing or derived from 1-phenylpropan-2-amine. Etilamfetamine is a very strong basic compound (based on its pKa). It can also be considered a substituted amphetamine, with an ethyl group on the amphetamine backbone. It most likely acts primarily as a dopamine releasing agent. It was invented in the early 20th century and was subsequently used as an anorectic or appetite suppressant in the 1950s, but was not as commonly used as other amphetamines such as amphetamine, methamphetamine, and benzphetamine, and was largely discontinued once newer drugs such as phenmetrazine were introduced. Its activity as a norepinephrine or serotonin releasing agent is not known. The molecular structure of ethylamphetamine is analogous to methamphetamine, with an ethyl group in place of the methyl group. At equipotent dosage, ethylamphetamine is subjectively less euphorigenic. Ethylamphetamine produces effects similar to amphetamine and methamphetamine, though its potency is less. Ethylamphetamine can be used as a recreational drug and, while its prevalence is less than amphetamine's, it is still encountered as a substance taken for recreational purposes. This compound has been identified in human blood as reported by (PMID: 31557052 ). Etilamfetamine is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Etilamfetamine is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | InChI=1S/C11H17N/c1-3-12-10(2)9-11-7-5-4-6-8-11/h4-8,10,12H,3,9H2,1-2H3 |
---|
Synonyms | Value | Source |
---|
Ethylamphetamine hydrochloride, (R)-isomer | MeSH | Ethylamphetamine hydrochloride, (+-)-isomer | MeSH | Ethylamphetamine hydrochloride | MeSH | Ethylamphetamine, (R)-isomer | MeSH | N-Ethylamphetamine | MeSH | Ethylamphetamine | MeSH |
|
---|
Chemical Formula | C11H17N |
---|
Average Molecular Weight | 163.264 |
---|
Monoisotopic Molecular Weight | 163.136099551 |
---|
IUPAC Name | ethyl(1-phenylpropan-2-yl)amine |
---|
Traditional Name | ethylamphetamine |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCNC(C)CC1=CC=CC=C1 |
---|
InChI Identifier | InChI=1S/C11H17N/c1-3-12-10(2)9-11-7-5-4-6-8-11/h4-8,10,12H,3,9H2,1-2H3 |
---|
InChI Key | YAGBSNMZQKEFCO-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as amphetamines and derivatives. These are organic compounds containing or derived from 1-phenylpropan-2-amine. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Phenethylamines |
---|
Direct Parent | Amphetamines and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Amphetamine or derivatives
- Phenylpropane
- Aralkylamine
- Secondary amine
- Secondary aliphatic amine
- Organic nitrogen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Organonitrogen compound
- Amine
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Etilamfetamine,1TMS,isomer #1 | CCN(C(C)CC1=CC=CC=C1)[Si](C)(C)C | 1426.5 | Semi standard non polar | 33892256 | Etilamfetamine,1TMS,isomer #1 | CCN(C(C)CC1=CC=CC=C1)[Si](C)(C)C | 1486.2 | Standard non polar | 33892256 | Etilamfetamine,1TMS,isomer #1 | CCN(C(C)CC1=CC=CC=C1)[Si](C)(C)C | 1733.0 | Standard polar | 33892256 | Etilamfetamine,1TBDMS,isomer #1 | CCN(C(C)CC1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 1675.4 | Semi standard non polar | 33892256 | Etilamfetamine,1TBDMS,isomer #1 | CCN(C(C)CC1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 1713.0 | Standard non polar | 33892256 | Etilamfetamine,1TBDMS,isomer #1 | CCN(C(C)CC1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 1872.3 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Etilamfetamine GC-MS (Non-derivatized) - 70eV, Positive | splash10-00dl-9300000000-3e87200c869459195f86 | 2017-08-28 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Etilamfetamine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Etilamfetamine 10V, Positive-QTOF | splash10-03di-1900000000-e763a8072f92243c890a | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Etilamfetamine 20V, Positive-QTOF | splash10-03xr-5900000000-aee1f50400412e7fb6a8 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Etilamfetamine 40V, Positive-QTOF | splash10-002f-9200000000-3f13b2c9cae5548f3d1c | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Etilamfetamine 10V, Negative-QTOF | splash10-03di-0900000000-a76552496d84fa003df5 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Etilamfetamine 20V, Negative-QTOF | splash10-03di-2900000000-3b10d568fede79216549 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Etilamfetamine 40V, Negative-QTOF | splash10-0006-9200000000-6281cbb04f1dfcf823ff | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Etilamfetamine 10V, Positive-QTOF | splash10-03xu-4900000000-1ad528ca64b13f050516 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Etilamfetamine 20V, Positive-QTOF | splash10-0006-9100000000-7fc53fe3402f7464cba0 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Etilamfetamine 40V, Positive-QTOF | splash10-0006-9000000000-ee5d7287ffe03eb231f8 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Etilamfetamine 10V, Negative-QTOF | splash10-03dl-8900000000-891ce0d72aa47b4b00ed | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Etilamfetamine 20V, Negative-QTOF | splash10-00kf-7900000000-9b7b1e64060422e987ff | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Etilamfetamine 40V, Negative-QTOF | splash10-0006-9100000000-f0f57a6518ea3dc29432 | 2021-10-12 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | Not Available |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected but not Quantified | Not Quantified | Not Specified | Not Specified | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB13285 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | Not Available |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Etilamfetamine |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 9982 |
---|
PDB ID | Not Available |
---|
ChEBI ID | Not Available |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]
|
---|